🇺🇸 FDA
Patent

US 7566451

Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency

granted A61KA61K2039/505A61K2039/605

Quick answer

US patent 7566451 (Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K2039/605, A61K39/12, A61K39/21